title: Metanephric adenosarcoma in a young adult: morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses: a case report and review of the literature.
abstract: Metanephric neoplasms are uncommon renal tumors that arise in both children and adults. They may be composed of small epithelial cells or benign stroma, or both, and are termed metanephric adenoma, metanephric stromal tumor, or metanephric adenofibroma, respectively. Thus far, these tumors have been known for their benign behavior. We present the case of a 21-year-old woman who developed a neoplasm composed of a renal epithelial component identical to metanephric adenoma combined with a malignant spindle cell sarcoma. The epithelial component was positive for pankeratin AE1/3, whereas the sarcomatous component was negative for epithelial markers and positive for vimentin, CD34, and CD117. No smooth muscle differentiation was apparent in the sarcoma by immunohistochemistry or ultrastructural analysis. By fluorescent in situ hybridization analysis of the sarcomatous component there was monosomy of the X chromosome, but no apparent variation from the normal diploid pattern for chromosomes 3, 7, 12, and 17. We conclude that the spectrum of metanephric neoplasia should be expanded to include malignant stromal variants, and we propose the term "metanephric adenosarcoma" for the present case.
authors.affiliation: Department of Pathology, Loyola University Medical Center, Chicago, Illinois 60153, USA. mpicken@lumc.edu
authors.forename: M M
authors.initials: MM
authors.lastname: Picken
authors.forename: J L
authors.initials: JL
authors.lastname: Curry
authors.forename: V
authors.initials: V
authors.lastname: Lindgren
authors.forename: J I
authors.initials: JI
authors.lastname: Clark
authors.forename: J N
authors.initials: JN
authors.lastname: Eble
mesh_terms: D018195:Adenosarcoma / Q000737:chemistry / Q000556:secondary* / Q000628:therapy; D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D004273:DNA, Neoplasm / Q000032:analysis; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D007680:Kidney Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000628:therapy; D012509:Sarcoma / Q000737:chemistry / Q000235:genetics / Q000556:secondary* / Q000628:therapy; D014960:X Chromosome
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm